Ubs Asset Management Americas Inc Merus N.V. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Merus N.V. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 84,200 shares of MRUS stock, worth $4.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,200
Previous 71,988
16.96%
Holding current value
$4.18 Million
Previous $4.26 Million
1.24%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MRUS
# of Institutions
200Shares Held
61.9MCall Options Held
243KPut Options Held
300K-
Rtw Investments, LP New York, NY4.17MShares$207 Million3.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$169 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$166 Million14.22% of portfolio
-
Wellington Management Group LLP Boston, MA2.89MShares$143 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$130 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.28B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...